Overview
Roger Lacave practices practicing medicine in Paris, France.
Mr. Lacave is highly rated in 1 condition, according to our data. His clinical expertise encompasses EGFR Positive Lung Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC).
He is actively involved in clinical research, co-authoring 26 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Roger Lacave
Is Roger Lacave a top-rated expert for EGFR Positive Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Roger Lacave is classified as an Advanced expert for EGFR Positive Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Roger Lacave participate in research or clinical trials?
Yes. Roger Lacave has published 26 articles and abstracts on conditions like EGFR Positive Lung Cancer. You can view a list of Roger Lacave's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerMr. Lacave isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Langerhans Cell HistiocytosisMr. Lacave isExperienced. Learn about Langerhans Cell Histiocytosis.
- Lung AdenocarcinomaMr. Lacave isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerMr. Lacave isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Lacave isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- PIK3CA-Related Overgrowth SpectrumMr. Lacave isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Small Cell Lung Cancer (SCLC)Mr. Lacave isExperienced. Learn about Small Cell Lung Cancer (SCLC).